$CAPRCapricor Therapeutics, Inc.
WatchBuildingOpportunity 51/100AI Score 50/1002 sources$1.5B
Social signal only — $CAPR is trending on StockTwits and Twitter with discussions around a price target of $58 due to confidence in Deramiocel approval by the upcoming PDUFA date on August 22nd. No i…
Loading...